Pro-Dex, Inc. (PDEX)
USD 45.73
(-5.61%)
USD 45.73
(-5.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 14.55 Million USD | 14.13% |
| 2023 | 12.74 Million USD | -2.92% |
| 2022 | 13.13 Million USD | -3.26% |
| 2021 | 13.57 Million USD | 3.29% |
| 2020 | 13.14 Million USD | 34.38% |
| 2019 | 9.78 Million USD | 23.13% |
| 2018 | 7.94 Million USD | 10.53% |
| 2017 | 7.18 Million USD | 33.0% |
| 2016 | 5.4 Million USD | 45.87% |
| 2015 | 3.7 Million USD | 24.88% |
| 2014 | 2.96 Million USD | -20.18% |
| 2013 | 3.71 Million USD | -31.39% |
| 2012 | 5.41 Million USD | -48.6% |
| 2011 | 10.53 Million USD | 25.97% |
| 2010 | 8.36 Million USD | 23.95% |
| 2009 | 6.74 Million USD | -17.8% |
| 2008 | 8.2 Million USD | 11.43% |
| 2007 | 7.36 Million USD | 12.03% |
| 2006 | 6.57 Million USD | -7.12% |
| 2005 | 7.08 Million USD | 4.04% |
| 2004 | 6.8 Million USD | 38.45% |
| 2003 | 4.91 Million USD | 19.88% |
| 2002 | 4.1 Million USD | -39.3% |
| 2001 | 6.75 Million USD | -53.56% |
| 2000 | 14.54 Million USD | 69.54% |
| 1999 | 8.57 Million USD | -32.08% |
| 1998 | 12.63 Million USD | 14.82% |
| 1997 | 11 Million USD | -15.38% |
| 1996 | 13 Million USD | 96.97% |
| 1995 | 6.6 Million USD | 15.79% |
| 1994 | 5.7 Million USD | 72.73% |
| 1993 | 3.3 Million USD | -17.5% |
| 1992 | 4 Million USD | 471.43% |
| 1991 | 700 Thousand USD | -22.22% |
| 1990 | 900 Thousand USD | 50.0% |
| 1989 | 600 Thousand USD | 100.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 4.1 Million USD | 46.47% |
| 2024 Q2 | 2.8 Million USD | -23.4% |
| 2024 Q1 | 3.65 Million USD | 8.9% |
| 2024 FY | 14.81 Million USD | 16.23% |
| 2024 Q4 | 4.19 Million USD | 2.19% |
| 2023 Q2 | 2.62 Million USD | -11.27% |
| 2023 Q4 | 3.35 Million USD | -11.86% |
| 2023 Q1 | 2.95 Million USD | -14.12% |
| 2023 FY | 12.74 Million USD | -2.92% |
| 2023 Q3 | 3.81 Million USD | 45.29% |
| 2022 Q1 | 3.42 Million USD | 9.91% |
| 2022 Q4 | 3.44 Million USD | 20.43% |
| 2022 Q3 | 2.85 Million USD | -16.04% |
| 2022 Q2 | 3.4 Million USD | -0.7% |
| 2022 FY | 13.13 Million USD | -3.26% |
| 2021 Q1 | 3.47 Million USD | -18.96% |
| 2021 Q2 | 2.59 Million USD | -25.29% |
| 2021 Q4 | 3.11 Million USD | -28.87% |
| 2021 Q3 | 4.38 Million USD | 68.91% |
| 2021 FY | 13.57 Million USD | 3.29% |
| 2020 FY | 13.14 Million USD | 34.38% |
| 2020 Q3 | 3.21 Million USD | 12.08% |
| 2020 Q2 | 2.86 Million USD | 3.02% |
| 2020 Q1 | 2.78 Million USD | 9.36% |
| 2020 Q4 | 4.28 Million USD | 33.58% |
| 2019 Q3 | 2.26 Million USD | 0.62% |
| 2019 FY | 9.78 Million USD | 23.13% |
| 2019 Q4 | 2.54 Million USD | 12.33% |
| 2019 Q1 | 2.72 Million USD | 14.15% |
| 2019 Q2 | 2.24 Million USD | -17.53% |
| 2018 Q2 | 1.71 Million USD | -7.69% |
| 2018 Q4 | 2.38 Million USD | 20.9% |
| 2018 Q3 | 1.97 Million USD | 15.08% |
| 2018 FY | 7.94 Million USD | 10.53% |
| 2018 Q1 | 1.86 Million USD | -6.58% |
| 2017 Q3 | 2.46 Million USD | 87.8% |
| 2017 Q4 | 1.99 Million USD | -19.13% |
| 2017 FY | 7.18 Million USD | 33.0% |
| 2017 Q1 | 1.6 Million USD | 11.28% |
| 2017 Q2 | 1.31 Million USD | -18.47% |
| 2016 FY | 5.4 Million USD | 45.87% |
| 2016 Q4 | 1.44 Million USD | 6.25% |
| 2016 Q2 | 1.53 Million USD | 45.46% |
| 2016 Q3 | 1.36 Million USD | -11.63% |
| 2016 Q1 | 1.05 Million USD | -6.7% |
| 2015 FY | 3.7 Million USD | 24.88% |
| 2015 Q1 | 828 Thousand USD | -11.06% |
| 2015 Q2 | 696 Thousand USD | -15.94% |
| 2015 Q4 | 1.13 Million USD | 8.52% |
| 2015 Q3 | 1.04 Million USD | 50.14% |
| 2014 FY | 2.96 Million USD | -20.18% |
| 2014 Q4 | 931 Thousand USD | 72.41% |
| 2014 Q3 | 540 Thousand USD | -1.64% |
| 2014 Q2 | 549 Thousand USD | -41.9% |
| 2014 Q1 | 945 Thousand USD | 67.26% |
| 2013 FY | 3.71 Million USD | -31.39% |
| 2013 Q3 | 883 Thousand USD | -14.52% |
| 2013 Q2 | 1.03 Million USD | -16.42% |
| 2013 Q1 | 1.23 Million USD | 44.06% |
| 2013 Q4 | 565 Thousand USD | -36.01% |
| 2012 Q3 | 1.2 Million USD | -14.26% |
| 2012 FY | 5.41 Million USD | -48.6% |
| 2012 Q4 | 858 Thousand USD | -28.68% |
| 2012 Q2 | 1.4 Million USD | -39.76% |
| 2012 Q1 | 2.32 Million USD | -23.66% |
| 2011 FY | 10.53 Million USD | 25.97% |
| 2011 Q1 | 2.18 Million USD | -0.64% |
| 2011 Q2 | 2.42 Million USD | 10.99% |
| 2011 Q3 | 2.87 Million USD | 18.69% |
| 2011 Q4 | 3.05 Million USD | 6.05% |
| 2010 Q3 | 2.29 Million USD | 14.6% |
| 2010 Q4 | 2.19 Million USD | -4.1% |
| 2010 Q2 | 2 Million USD | 6.72% |
| 2010 FY | 8.36 Million USD | 23.95% |
| 2010 Q1 | 1.87 Million USD | -3.9% |
| 2009 Q1 | 1.75 Million USD | 18.75% |
| 2009 Q2 | 1.93 Million USD | 10.15% |
| 2009 FY | 6.74 Million USD | -17.8% |
| 2009 Q3 | 1.11 Million USD | -42.49% |
| 2009 Q4 | 1.95 Million USD | 75.52% |
| 2008 FY | 8.2 Million USD | 11.43% |
| 2008 Q2 | 2.35 Million USD | 9.34% |
| 2008 Q3 | 2.22 Million USD | -5.44% |
| 2008 Q4 | 1.47 Million USD | -33.65% |
| 2008 Q1 | 2.15 Million USD | 15.69% |
| 2007 Q4 | 1.86 Million USD | -13.68% |
| 2007 Q1 | 1.98 Million USD | 16.39% |
| 2007 FY | 7.36 Million USD | 12.03% |
| 2007 Q2 | 1.36 Million USD | -30.89% |
| 2007 Q3 | 2.15 Million USD | 57.49% |
| 2006 Q4 | 1.7 Million USD | 16.98% |
| 2006 Q3 | 1.45 Million USD | -15.8% |
| 2006 Q2 | 1.72 Million USD | 2.19% |
| 2006 Q1 | 1.69 Million USD | -13.64% |
| 2006 FY | 6.57 Million USD | -7.12% |
| 2005 FY | 7.08 Million USD | 4.04% |
| 2005 Q1 | 1.86 Million USD | -4.81% |
| 2005 Q2 | 1.61 Million USD | -12.96% |
| 2005 Q3 | 1.64 Million USD | 1.48% |
| 2005 Q4 | 1.95 Million USD | 19.17% |
| 2004 Q3 | 1.6 Million USD | -6.03% |
| 2004 Q2 | 1.7 Million USD | 10.77% |
| 2004 Q4 | 1.95 Million USD | 21.82% |
| 2004 FY | 6.8 Million USD | 38.45% |
| 2004 Q1 | 1.54 Million USD | 16.13% |
| 2003 Q1 | 1.15 Million USD | 89.14% |
| 2003 FY | 4.91 Million USD | 19.88% |
| 2003 Q4 | 1.32 Million USD | 12.46% |
| 2003 Q3 | 1.18 Million USD | -6.2% |
| 2003 Q2 | 1.25 Million USD | 9.39% |
| 2002 Q3 | 1.11 Million USD | 13.18% |
| 2002 Q4 | 608 Thousand USD | -45.52% |
| 2002 FY | 4.1 Million USD | -39.3% |
| 2002 Q1 | 1.39 Million USD | 143.96% |
| 2002 Q2 | 986 Thousand USD | -29.06% |
| 2001 Q2 | 3.98 Million USD | 12.85% |
| 2001 Q3 | 2.37 Million USD | -40.47% |
| 2001 FY | 6.75 Million USD | -53.56% |
| 2001 Q4 | -3.16 Million USD | -233.31% |
| 2001 Q1 | 3.53 Million USD | -15.53% |
| 2000 Q3 | 3.48 Million USD | -17.0% |
| 2000 FY | 14.54 Million USD | 69.54% |
| 2000 Q4 | 4.18 Million USD | 19.91% |
| 2000 Q2 | 4.2 Million USD | 55.56% |
| 2000 Q1 | 2.7 Million USD | 18.47% |
| 1999 Q2 | 1.9 Million USD | -26.92% |
| 1999 Q4 | 2.27 Million USD | 13.95% |
| 1999 Q3 | 2 Million USD | 5.26% |
| 1999 Q1 | 2.6 Million USD | 2.76% |
| 1999 FY | 8.57 Million USD | -32.08% |
| 1998 FY | 12.63 Million USD | 14.82% |
| 1998 Q1 | 3.5 Million USD | 12.9% |
| 1998 Q2 | 3.7 Million USD | 5.71% |
| 1998 Q3 | 2.9 Million USD | -21.62% |
| 1998 Q4 | 2.53 Million USD | -12.75% |
| 1997 Q4 | 3.1 Million USD | 29.17% |
| 1997 Q2 | 2.9 Million USD | 11.54% |
| 1997 Q1 | 2.6 Million USD | -18.75% |
| 1997 Q3 | 2.4 Million USD | -17.24% |
| 1997 FY | 11 Million USD | -15.38% |
| 1996 Q1 | 2.7 Million USD | 58.82% |
| 1996 Q3 | 3.9 Million USD | 21.88% |
| 1996 FY | 13 Million USD | 96.97% |
| 1996 Q4 | 3.2 Million USD | -17.95% |
| 1996 Q2 | 3.2 Million USD | 18.52% |
| 1995 Q3 | 1.5 Million USD | -11.76% |
| 1995 Q4 | 1.7 Million USD | 13.33% |
| 1995 Q2 | 1.7 Million USD | -19.05% |
| 1995 Q1 | 2.1 Million USD | -22.22% |
| 1995 FY | 6.6 Million USD | 15.79% |
| 1994 Q2 | 1.1 Million USD | 10.0% |
| 1994 Q3 | 1 Million USD | -9.09% |
| 1994 Q4 | 2.7 Million USD | 170.0% |
| 1994 FY | 5.7 Million USD | 72.73% |
| 1994 Q1 | 1 Million USD | -9.09% |
| 1993 Q3 | 800 Thousand USD | -33.33% |
| 1993 FY | 3.3 Million USD | -17.5% |
| 1993 Q4 | 1.1 Million USD | 37.5% |
| 1993 Q1 | 1.1 Million USD | -15.38% |
| 1993 Q2 | 1.2 Million USD | 9.09% |
| 1992 Q3 | 1.1 Million USD | -8.33% |
| 1992 FY | 4 Million USD | 471.43% |
| 1992 Q4 | 1.3 Million USD | 18.18% |
| 1992 Q1 | 1.1 Million USD | 120.0% |
| 1992 Q2 | 1.2 Million USD | 9.09% |
| 1991 Q1 | 500 Thousand USD | 0.0% |
| 1991 Q2 | 500 Thousand USD | 0.0% |
| 1991 FY | 700 Thousand USD | -22.22% |
| 1991 Q3 | 600 Thousand USD | 20.0% |
| 1991 Q4 | 500 Thousand USD | -16.67% |
| 1990 Q4 | 500 Thousand USD | -16.67% |
| 1990 FY | 900 Thousand USD | 50.0% |
| 1990 Q2 | 500 Thousand USD | -16.67% |
| 1990 Q1 | 600 Thousand USD | 20.0% |
| 1990 Q3 | 600 Thousand USD | 20.0% |
| 1989 Q4 | 500 Thousand USD | 25.0% |
| 1989 Q1 | 600 Thousand USD | -14.29% |
| 1989 Q2 | 500 Thousand USD | -16.67% |
| 1989 FY | 600 Thousand USD | 100.0% |
| 1989 Q3 | 400 Thousand USD | -20.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 74.157% |
| AngioDynamics, Inc. | 154.69 Million USD | 90.594% |
| AtriCure, Inc. | 300.37 Million USD | 95.156% |
| Avinger, Inc. | 2 Million USD | -626.46% |
| Azenta, Inc. | 263.14 Million USD | 94.47% |
| BioLife Solutions, Inc. | 46.75 Million USD | 68.876% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 99.383% |
| Daxor Corporation | 1.1 Million USD | -1218.694% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -60.271% |
| Femasys Inc. | 691.9 Thousand USD | -2003.047% |
| GlucoTrack, Inc. | -13 Thousand USD | 112030.769% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 76.093% |
| Hologic, Inc. | 2.22 Billion USD | 99.347% |
| ICU Medical, Inc. | 739.87 Million USD | 98.033% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.692% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 12.911% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 88.547% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 12294.018% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 12294.018% |
| Masimo Corporation | 1 Billion USD | 98.55% |
| Microbot Medical Inc. | -106 Thousand USD | 13827.358% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 56.033% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 97.508% |
| Nephros, Inc. | 8.4 Million USD | -73.123% |
| NovoCure Limited | 381.05 Million USD | 96.181% |
| NEXGEL, Inc. | 619 Thousand USD | -2250.727% |
| NEXGEL, Inc. | 619 Thousand USD | -2250.727% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 2707.706% |
| OraSure Technologies, Inc. | 179.42 Million USD | 91.89% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 1305.551% |
| Predictive Oncology Inc. | 1.14 Million USD | -1170.5% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -150.976% |
| QuidelOrtho Corporation | 1.49 Billion USD | 99.026% |
| Repligen Corporation | 315.22 Million USD | 95.384% |
| Sanara MedTech Inc. | 57.13 Million USD | 74.533% |
| STAAR Surgical Company | 252.65 Million USD | 94.241% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 1732.654% |
| Utah Medical Products, Inc. | 30.03 Million USD | 51.558% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 99.302% |
| Jin Medical International Ltd. | 6.78 Million USD | -114.464% |